Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44027690HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44033127HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44003490HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44003251HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44047888HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44035075HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TVIS44047887HTLV-1ENSG00000171105.14protein_codingINSRYesNo3643P06213
TCGA Plot Options
Drug Information
GeneINSR
DrugBank IDDB01307
Drug NameInsulin detemir
Target IDBE0000033
UniProt IDP06213
Regulation Typeagonist
PubMed IDs16570163; 10866053; 20590743; 18585815; 11752352
CitationsHennige AM, Sartorius T, Tschritter O, Preissl H, Fritsche A, Ruth P, Haring HU: Tissue selectivity of insulin detemir action in vivo. Diabetologia. 2006 Jun;49(6):1274-82. Epub 2006 Mar 29.@@Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T: Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 2000 Jun;49(6):999-1005.@@Sorensen AR, Stidsen CE, Ribel U, Nishimura E, Sturis J, Jonassen I, Bouman SD, Kurtzhals P, Brand CL: Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor. Diabetes Obes Metab. 2010 Aug;12(8):665-73. doi: 10.1111/j.1463-1326.2010.01206.x.@@Wada T, Azegami M, Sugiyama M, Tsuneki H, Sasaoka T: Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin. Diabetes Res Clin Pract. 2008 Sep;81(3):269-77. doi: 10.1016/j.diabres.2008.05.007. Epub 2008 Jun 27.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA164746470
ChEMBLCHEMBL2104391